Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Bioterrorism & Biodefense|December 4, 2012
Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in RodentsJason S Richardson, Gary Wong, Stéphane Pillet, et al.Journal of Bacteriology|December 25, 2007
RhaU of Rhizobium leguminosarum is a rhamnose mutarotaseJason S Richardson, Xavi Carpena, Jack Switala, et al.Plos One|April 25, 2009
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccineJason S Richardson, Michel K Yao, Kaylie N Tran, et al.The American Journal of Tropical Medicine and Hygiene|October 5, 2021
Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus ImmunoglobulinJane White, Priya Tunga, Deborah M Anderson, et al.Journal of Virology|November 14, 2014
Ebola virus transmission in guinea pigsGary Wong, Xiangguo Qiu, Jason S Richardson, et al.The Journal of Infectious Diseases|May 17, 2011
Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigsGary P Kobinger, Anders Leung, James Neufeld, et al.The Journal of Infectious Diseases|May 11, 2015
Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman PrimatesGary Wong, Jason S Richardson, Stéphane Pillet, et al.Plos One|September 1, 2012
Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccinesAmi Patel, Jessica C Dong, Brett Trost, et al.Science Translational Medicine|November 2, 2012
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primatesGary Wong, Jason S Richardson, Stéphane Pillet, et al.Vaccine|September 10, 2023
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individualsJames M McCarty, Lisa Bedell, Jason Mendy, et al.Pageof 3